• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

ETHSX:US

14.25 USD 0.04 0.28%

As of 09:29:30 ET on 11/21/2014.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (ETHSX)

Year To Date: +26.78% 3-Month: +10.12% 3-Year: +31.02% 52-Week Range: 10.78 - 14.32
1-Month: +6.42% 1-Year: +30.42% 5-Year: +20.83% Beta vs SPX: 0.97

Mutual Fund Chart for ETHSX

No chart data available.
  • ETHSX:US 14.25
  • 1M
  • 1Y
Interactive ETHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 07-26-1985 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for ETHSX

NAV (on 2014-11-21) 14.25
Assets (M) (on 2014-10-31) 1,603.49
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for ETHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-17) 0.20
Dividend Yield (ttm) 10.06

Fees & Expenses for ETHSX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.91
Redemption Fee 1.00
12b1 Fee 0.25
Expense Ratio 1.46

Top Fund Holdings for ETHSX

Filing Date: 08/31/2014
Name Position Value % of Total
Roche Holding AG 293,000 85,572,969 5.715%
Gilead Sciences Inc 600,000 64,548,000 4.311%
AbbVie Inc 1,140,000 63,019,200 4.209%
Bristol-Myers Squibb Co 1,230,000 62,299,500 4.161%
HCA Holdings Inc 842,000 58,788,440 3.926%
Merck & Co Inc 932,000 56,022,520 3.741%
Amgen Inc 392,000 54,636,960 3.649%
Regeneron Pharmaceuticals Inc 153,000 53,629,560 3.582%
Biogen Idec Inc 149,600 51,318,784 3.427%
Medivation Inc 522,000 47,637,720 3.182%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil